Shares of Natco Pharma Ltd. jumped nearly 7% on Tuesday to the highest level in over three months after the company reported a higher-than-expected consolidated net profit and revenue in the fourth quarter of financial year 2024.
Natco Q4 FY24 Earnings Highlights (Consolidated, YoY)
Revenue up 19% to Rs 1,068 crore versus Rs 898 crore (Bloomberg estimate: Rs 952 crore).
Ebitda up 47% to Rs 497 crore versus Rs 339 crore.
Margin at 46.6% vs 37.8%.
Net profit up 40% to Rs 386 crore versus Rs 276 crore (Estimate: Rs 338 crore).
On the NSE, Natco's stock rose as much as 6.86% during the day to Rs 1,100 apiece, the highest since Feb. 19. It was trading 4.3% higher at Rs 1,073.20 per share, compared to a 0.13% advance in the benchmark Nifty at 9:45 a.m.
The share price has risen 32.27% on a year-to-date basis and 73.55% in the last 12 months. The total traded volume on the NSE so far in the day stood at 3.92 times its 30-day average. The relative strength index was at 71.44, indicating that the stock may be overbought.
Out of the 14 analysts tracking the company, nine have a 'buy' rating on the stock, three recommend 'hold' and two suggest 'sell', according to Bloomberg data. The average of 12-month analyst price targets implies a potential downside of 6.5%.
RECOMMENDED FOR YOU
Muthoot Finance Shares Surge 10%, Hit Upper Circuit After Q1 Profit Zooms
Aug 14, 2025
Oil India Q1 Results: Profit, Revenue Beat Estimates
Aug 12, 2025
Stock Market Today: Nifty, Sensex Extend Declines For Second Day As Tariff Uncertainty Looms
Aug 06, 2025
Bajaj Finance, Tata Communications, Delhivery, ACC, MTAR Tech, NATCO Pharma, UPL Are Buzzing On Dealers' Desk
Jul 03, 2025
POPULAR